Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2025-12-25 @ 2:24 AM
NCT ID:
NCT03252834
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 20 years old
* Pathological stage I\~IV for ovarian cancer, stage II\~IV for endometrial cancer, or stage III for colorectal cancer.
* Scheduled to receive adjuvant Paclitaxel/Carboplatin for ovarian or endometrial cancer, or mFOLFOX6 for colorectal cancer.
* Patient willing to provide blood sample for research purposes.
* Ability of the patient to provide informed consent.
Exclusion Criteria:
* Prior treatment with neurotoxic chemotherapy, such as oxaliplatin, cisplatin, carboplatin, taxanes or vinca alkaloids.
* Receiving chemotherapy within 6 months.
* A family history of a genetic or familial neuropathy
* Poor compliance
Sex:
ALL
Minimum Age:
20 Years
Study:
NCT03252834
Study Brief:
Protocol Section:
NCT03252834